Abiopharma

Clinical trial NCT03876769 updates: 1. completion date: 2027-11-02 → 2027-10-19 2. primary completion date: 2027-11-02 → 2027-10-19

Clinical trial NCT07623057 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-23 3. enrollment: 56 → 48 participants

Clinical trial NCT07008469 updates: 1. primary completion date: 2030-08-01 → 2030-10-01 2. enrollment: 230 → 199 participants

Clinical trial NCT07465666 updates: 1. start date: 2026-08-01 → 2026-08-15 2. completion date: 2027-08-02 → 2027-08-15 3. primary completion date: 2027-08-02 → 2027-08-15

Clinical trial NCT05145816 updates: 1. completion date: 2026-09-01 → 2027-09-01 2. primary completion date: 2026-03-01 → 2027-03-01

Clinical trial NCT07635147: start date: 2026-06-01 → 2026-06-17.

Clinical trial NCT06832618 updates: 1. completion date: 2028-05-18 → 2027-09-06 2. primary completion date: 2026-07-13 → 2026-08-07

Clinical trial NCT07693868: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT05919108: start date: 2024-05-30 → 2024-06-11.

Clinical trial NCT05568706: enrollment: 186 → 187 participants.

Clinical trial NCT07085416 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-18 → 2026-01-15 3. primary completion date: 2026-03-31 → 2026-01-15 4. enrollment: 60 → 20 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07551505: status: NOT_YET_RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05497336 updates: 1. status: UNKNOWN → TERMINATED 2. completion date: 2024-09-30 → 2025-01-24 3. primary completion date: 2023-08-30 → 2025-01-24 4. enrollment: 80 → 8 participants 5. enrollment type: ESTIMATED → ACTUAL

General Announcement: Disclosure pursuant to Rule 704(31) of the SGX-ST Listing Manual

Clinical trial NCT05424783 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-12-31 → 2027-02-01 3. primary completion date: 2026-06-30 → 2027-02-01